NCT01632644

Brief Summary

The primary objective of this study is to investigate the patient experience during skin biopsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2012

Completed
4 days until next milestone

Study Start

First participant enrolled

July 1, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 3, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
Last Updated

December 6, 2021

Status Verified

December 1, 2021

Enrollment Period

10 months

First QC Date

June 27, 2012

Last Update Submit

December 2, 2021

Conditions

Identification of Skin Cancer Biopsy Sites

Outcome Measures

Primary Outcomes (1)

  • Review of Physician and Patient Experience

    Subjects will answer a combination of: 1. Open-ended questions and 2. Questions asking for subject to rank possible responses

    Last four weeks of study

Secondary Outcomes (2)

  • Physician's Experience with Skin Biopsy Sites

    First four weeks of study

  • Patient's Experience with Skin Biopsy Sites

    First four weeks of study

Study Arms (2)

Physicians

Physicians performing skin biopsies

Other: Survey/Interview

Patients

Patients who have had skin biopsies

Other: Survey/Interview

Interventions

Survey/InterviewOTHER

Each group will be surveyed and interviewed.

PatientsPhysicians

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Physicians will be recruited by email obtained through directories. Patients will be those who have had biopsies at the Northwestern University Department of Dermatology.

You may qualify if:

  • Age 18 and Over
  • The subjects are in good health.
  • The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
  • Patients who have had one or multiple skin biopsies OR board-certified dermatologists.

You may not qualify if:

  • Under 18 years of age.
  • Subjects who are unable to understand the protocol or give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern University Dermatology

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Interventions

Surveys and QuestionnairesInterviews as Topic

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Murad Alam, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Dermatology

Study Record Dates

First Submitted

June 27, 2012

First Posted

July 3, 2012

Study Start

July 1, 2012

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

December 6, 2021

Record last verified: 2021-12

Locations

US(1)